Hi ,

We hope this finds you well.

These are indeed interesting times in synthetic biology. While the world wrestles with what seems to be almost non-stop bad news, we at Built With Biology are grateful for those of you who are diligently working through the adversity… developing planet-friendly products and services to feed, fuel and heal the world. For example, see our Spotlights below to learn how Eden Bio is using their machine learning platform to discover and optimize cellular pathways to produce biomaterials (e.g., spider silk), while Artificial is automating and streamlining life science discovery pipelines… all while keeping humans in the loop!

To gain even further insight into how biotech is advancing, please plan to join us for today’s highly informative digital symposium "Digital Genome Engineering," brought to you by Inscripta®. Whether you’re a metabolic engineer optimizing lysine biosynthesis in E. coli or seeking to conduct a genome-wide functional genomics screen in yeast, Digital Genome Engineering is the key to unlocking the limitless applications of synthetic biology. To attend this FREE event (9:00-11:30 PST), please click here to sign up, and join the event on Swapcard!

Lastly, we hope you’re all planning to attend the Built With Biology global conference on April 12-14 in Oakland, CA (USA). This live, in-person event will feature an amazing array of speakers, start-ups, press, and investors… all focused on the people and companies using biology to make the planet a better place. To sign up, please click here or contact us at info@builtwithbiology.com.

As always, thank you for reading. Stay safe and be well…!!

Larry

Larry Upton

Editor in Chief

larry.upton@builtwithbiology.com

Spotlight on: Eden Bio

The ability to produce new materials with microbes is what makes the bioeconomy possible. But how do we find the right genes to produce the best proteins through the most efficient pathways in a cell? The combinations of different factors are essentially infinite, impossible for humans to sort through without help. Meet Eden Bio, a company developing a machine learning platform to discover and optimize cellular pathways to produce biomaterials! Starting with spider silk proteins, the company is building out an ML platform to guide scientists and improve how microbes secrete and process proteins. Learn more about how Eden Bio is getting biomaterials out of the cell and into the world!

Spotlight on: Artificial

Automation is increasingly the norm in today’s bioeconomy. But how does one adopt automation in the first place? Many high-throughput biology tools and machines don’t connect to each other or share data. Meet Artificial, a company automating and streamlining life science discovery pipelines! The company creates software that is connected to a lab's existing software systems to schedule automated workflows and provide digital tools to augment and capture every manual step a human still needs to perform. Artificial can also help companies optimize their resources, from reagents to hands-on time for lab technicians. Learn more about how Artificial is helping companies bring critical discoveries like sustainable materials and medicines to market faster!

This stem cell manufacturing startup just raised an $80 million war chest to revolutionize medicine

Congratulations to Cellino Biotech, an autonomous cell therapy manufacturing company which announced an $80 million Series A financing round led by Leaps by Bayer.

Spotlight on: Eden Bio

Spotlight on: Artificial

This stem cell manufacturing startup just raised an $80 million war chest to revolutionize medicine

Built with Biology Podcast: Meet the Future, Deep Tech and SynBio

Mammoth Biosciences receives FDA Emergency Use Authorization for first CRISPR-based COVID-19 test

64x Bio raises $55 million to advance gene therapy platform